This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 7 EPO patents. Top assignees: Tokyo Medical and Dental University, Osaka University, The University of Tokyo. Active years: 2012-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
13 out of 135 
6 out of 1,043 
2 out of 1,356 
Years Active: 2012-2025
Title: Kazutaka Nishina: Innovator in Nucleic Acid Technology
Introduction
Kazutaka Nishina, based in Tokyo, Japan, is a distinguished inventor known for his significant contributions in the field of nucleic acid technology. With a total of 13 patents to his name, Nishina has developed innovative solutions that enhance our understanding of gene expression and transcription regulation.
Latest Patents
Among his most notable inventions are two patents concerning chimeric double-stranded nucleic acids. These inventions outline a method for reducing the level of transcription products in cells by utilizing a double-stranded nucleic acid complex. This complex consists of two strands: a first nucleic acid strand that hybridizes to the transcription product and a second strand composed of RNA nucleotides. The first strand contains elements such as a region of at least four consecutive nucleotides, which are recognized by RNase H, and nucleotide analogs on both the 5' and 3' terminal sides of this region. This innovative approach ranges from 8 to 35 nucleotides in total, potentially transforming therapeutic strategies in cellular biology.
Career Highlights
Kazutaka Nishina has had a distinguished career as a researcher and inventor. He has notably contributed to the academic environments of Tokyo Medical and Dental University and Osaka University, applying his expertise in biochemistry and molecular biology to push the boundaries of current scientific knowledge.
Collaborations
Nishina has had the opportunity to collaborate with noteworthy colleagues, including Takanori Yokota and Hidehiro Mizusawa. These collaborations have fostered advancements in research and have played a crucial role in the development of his innovative patents.
Conclusion
Kazutaka Nishina has established himself as a key figure in the field of nucleic acid research, particularly through his recent patents and collaborative efforts. His work not only enhances our understanding of molecular mechanisms but also sets the stage for future innovations that could have far-reaching impacts in medical and scientific communities.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile